ES2185218T3 - Un plasma sanguineo aplicable universalmente. - Google Patents

Un plasma sanguineo aplicable universalmente.

Info

Publication number
ES2185218T3
ES2185218T3 ES98945141T ES98945141T ES2185218T3 ES 2185218 T3 ES2185218 T3 ES 2185218T3 ES 98945141 T ES98945141 T ES 98945141T ES 98945141 T ES98945141 T ES 98945141T ES 2185218 T3 ES2185218 T3 ES 2185218T3
Authority
ES
Spain
Prior art keywords
blood plasma
blood
universally applicable
applicable blood
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98945141T
Other languages
English (en)
Other versions
ES2185218T5 (es
Inventor
Wolfgang Marguerre
Tor-Einar Svae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2185218(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma AG filed Critical Octapharma AG
Application granted granted Critical
Publication of ES2185218T3 publication Critical patent/ES2185218T3/es
Publication of ES2185218T5 publication Critical patent/ES2185218T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)

Abstract

La presente invención se refiere a un plasma sanguíneo universal que se puede obtener según un procedimiento que consiste en mezclar sangre o plasma sanguíneo de los grupos A y B y de forma opcional sangre o plasma sanguíneo del grupo AB sin tener que añadir cantidades importantes de sangre o plasma sanguíneo de grupo sanguíneo 0.
ES98945141T 1997-08-05 1998-08-04 Un plasma sanguineo aplicable universalmente. Expired - Lifetime ES2185218T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97113466A EP0896824A1 (en) 1997-08-05 1997-08-05 A universally applicable blood plasma
EP97113466 1997-08-05

Publications (2)

Publication Number Publication Date
ES2185218T3 true ES2185218T3 (es) 2003-04-16
ES2185218T5 ES2185218T5 (es) 2008-04-16

Family

ID=8227172

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98945141T Expired - Lifetime ES2185218T5 (es) 1997-08-05 1998-08-04 Un plasma sanguineo aplicable universalmente.

Country Status (25)

Country Link
US (1) US20110008459A1 (es)
EP (2) EP0896824A1 (es)
JP (1) JP2001513507A (es)
CN (1) CN1272061A (es)
AT (1) ATE225665T1 (es)
AU (1) AU742427B2 (es)
BG (1) BG64350B1 (es)
BR (1) BR9811839A (es)
CA (1) CA2299421C (es)
CZ (1) CZ293726B6 (es)
DE (1) DE69808620T3 (es)
DK (1) DK0991416T4 (es)
EA (1) EA003182B1 (es)
ES (1) ES2185218T5 (es)
HK (1) HK1026146A1 (es)
HU (1) HU226548B1 (es)
ID (1) ID24308A (es)
IL (1) IL134308A (es)
NO (1) NO326216B1 (es)
NZ (1) NZ502661A (es)
PL (1) PL193983B1 (es)
PT (1) PT991416E (es)
RS (1) RS50016B (es)
TW (1) TW555563B (es)
WO (1) WO1999007390A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
UA83528C2 (uk) * 2003-12-19 2008-07-25 Октафарма Аг Плазма крові, одержана з порцій плазми індивідуумів, що не належать до європеоїдної раси, та її застосування
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
US9867782B2 (en) 2009-04-09 2018-01-16 Entegrion, Inc. Spray-dried blood products and methods of making same
US8407912B2 (en) 2010-09-16 2013-04-02 Velico Medical, Inc. Spray dried human plasma
WO2011035062A2 (en) 2009-09-16 2011-03-24 Velico Medical, Inc. Spray dried human plasma
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
CN103338849A (zh) 2010-10-29 2013-10-02 维利科医学公司 用于对液体进行喷雾干燥的系统和方法
US20140083628A1 (en) 2012-09-27 2014-03-27 Velico Medical, Inc. Spray drier assembly for automated spray drying
US9561184B2 (en) 2014-09-19 2017-02-07 Velico Medical, Inc. Methods and systems for multi-stage drying of plasma
FR3026950A1 (fr) 2014-10-09 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de plasma universel
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
CA3078625C (en) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
FR3083121B1 (fr) 2018-06-27 2021-10-22 Maco Pharma Sa Procede de greffage d un element fibreux pour l elimination d anticorps du sang ou d un composant sanguin
WO2020185916A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma
US11998861B2 (en) 2022-09-15 2024-06-04 Velico Medical, Inc. Usability of a disposable for a spray drying plasma system
US11841189B1 (en) 2022-09-15 2023-12-12 Velico Medical, Inc. Disposable for a spray drying system
US12083447B2 (en) 2022-09-15 2024-09-10 Velico Medical, Inc. Alignment of a disposable for a spray drying plasma system
US11975274B2 (en) 2022-09-15 2024-05-07 Velico Medical, Inc. Blood plasma product

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
JPH0723319B2 (ja) * 1986-05-14 1995-03-15 株式会社ミドリ十字 血液製剤から血液型抗体を除去する方法
DE4008852A1 (de) † 1990-03-20 1991-09-26 Octapharma Ag Verfahren zur herstellung von nicht-infektioesem blutplasma
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
JP3575770B2 (ja) * 1992-03-31 2004-10-13 学校法人藤田学園 血漿由来製剤
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors

Also Published As

Publication number Publication date
NO326216B1 (no) 2008-10-20
BG104117A (en) 2000-12-29
DE69808620T3 (de) 2008-05-21
AU9256998A (en) 1999-03-01
EP0991416A1 (en) 2000-04-12
HUP0004795A3 (en) 2003-08-28
CZ293726B6 (cs) 2004-07-14
EP0991416B1 (en) 2002-10-09
RS50016B (sr) 2008-09-29
HU226548B1 (en) 2009-03-30
CN1272061A (zh) 2000-11-01
DE69808620T2 (de) 2003-06-26
US20110008459A1 (en) 2011-01-13
BG64350B1 (bg) 2004-11-30
CZ2000370A3 (cs) 2000-09-13
ES2185218T5 (es) 2008-04-16
ID24308A (id) 2000-07-13
CA2299421A1 (en) 1999-02-18
PL338794A1 (en) 2000-11-20
IL134308A0 (en) 2001-04-30
HUP0004795A2 (hu) 2001-04-28
IL134308A (en) 2004-09-27
PL193983B1 (pl) 2007-04-30
ATE225665T1 (de) 2002-10-15
BR9811839A (pt) 2000-08-15
HK1026146A1 (en) 2000-12-08
DE69808620D1 (de) 2002-11-14
EP0896824A1 (en) 1999-02-17
EA003182B1 (ru) 2003-02-27
EP0991416B2 (en) 2007-10-31
DK0991416T3 (da) 2003-02-10
EA200000196A1 (ru) 2000-10-30
NO20000578D0 (no) 2000-02-04
PT991416E (pt) 2003-02-28
AU742427B2 (en) 2002-01-03
NZ502661A (en) 2001-03-30
TW555563B (en) 2003-10-01
CA2299421C (en) 2009-11-10
NO20000578L (no) 2000-03-27
WO1999007390A1 (en) 1999-02-18
YU5800A (sh) 2003-02-28
JP2001513507A (ja) 2001-09-04
DK0991416T4 (da) 2008-02-25

Similar Documents

Publication Publication Date Title
ES2185218T3 (es) Un plasma sanguineo aplicable universalmente.
HN1998000118A (es) 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
MX190415B (es) Composiciones inhibidoras de transferencia de colorante que comprenden agentes dispersantes polimericos.
DE69719536D1 (de) Vorrichtung mit einer vielzahl von kapillaraktivität induzierenden flächen
AR240330A1 (es) Composicon de etileno y propileno y composicon polimerica que lo comprende.
MX9401195A (es) Oligomeros de esteres tapados en los extremos poli-etoxi/propoxisulfonados adecuados como agentes liberadores de sucio en composicionesdetergentes.
TR199700849T1 (xx) Hepatit B a��s�.
ES2022873B3 (es) Termoplasticos de ingenieria que contienen grupos de benzociclobuteno unidos.
ES2058346T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ES2183303T3 (es) Quelatos metalicos de derivados macrociclicos poliaminocarboxilicos y su aplicacion en la formacion de imagenes para diagnostico.
BE879791A (fr) Combinaison d'une prise de courant et d'un rail de tension, ainsi que l'une des parties de cette combinaison
DE3767331D1 (de) Zusammensetzung fuer haertende anstrichfarben.
DE69632643T2 (de) Verwendungen von nukleinsäuren die ein retrovirus aus schweinen entnommen sind
DK607387D0 (da) Antihypertensivt laegemiddel paa basis af diltiazem
BR9812448A (pt) Polìmeros de aminossiloxano-poliéter
ATE384075T1 (de) Markierte glutamin- und lysinanaloge
DE59909258D1 (de) Färbemittel mit enzymen
BR0114884A (pt) Compostos calcilìticos
SE9703413D0 (sv) Vehicle firewall
MX171160B (es) Generos de polimeros tratados
ES551996A0 (es) Procedimiento para la obtencion de conjugados de muramilpeptidos y correspondientes estereoisomeros que se derivan de lad-manosa o d-galactosa.
IT8048496A0 (it) Perfici di acciaio senza la emissio procedimento di metallizzazione in ne di fanghi di scarico particolare galvanizzazione di su
DK0412538T3 (da) Bladglansmiddel
NO853877L (no) Optisk integrert boelgelederkomponent.
ES2178830T3 (es) Procedimiento para la preparacion de tetraazamacrociclos.